CA2223385A1 - Stabilized steroid compositions - Google Patents

Stabilized steroid compositions Download PDF

Info

Publication number
CA2223385A1
CA2223385A1 CA002223385A CA2223385A CA2223385A1 CA 2223385 A1 CA2223385 A1 CA 2223385A1 CA 002223385 A CA002223385 A CA 002223385A CA 2223385 A CA2223385 A CA 2223385A CA 2223385 A1 CA2223385 A1 CA 2223385A1
Authority
CA
Canada
Prior art keywords
degradation
composition according
triamcinolone acetonide
edta
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002223385A
Other languages
English (en)
French (fr)
Inventor
Christianna L. Strohbeck
Chong Min Won
Sheng-Yuh Tang
Bih-Hsiung Hsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2223385A1 publication Critical patent/CA2223385A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
CA002223385A 1995-06-07 1996-06-05 Stabilized steroid compositions Abandoned CA2223385A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48533995A 1995-06-07 1995-06-07
US08/485,339 1995-06-07

Publications (1)

Publication Number Publication Date
CA2223385A1 true CA2223385A1 (en) 1996-12-19

Family

ID=23927770

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002223385A Abandoned CA2223385A1 (en) 1995-06-07 1996-06-05 Stabilized steroid compositions

Country Status (6)

Country Link
EP (1) EP0843548A4 (pt)
JP (1) JPH11507359A (pt)
AU (1) AU6164196A (pt)
BR (1) BR9608721A (pt)
CA (1) CA2223385A1 (pt)
WO (1) WO1996040042A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
EP1850831B1 (en) * 2005-02-25 2015-12-02 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
CA2673451C (en) 2006-12-21 2016-02-09 Nerviano Medical Sciences S.R.L. Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
EP3456314A1 (en) 2017-09-14 2019-03-20 Tiofarma B.V. Topical formulation comprising 17-ketolic corticosteroid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
AU662101B2 (en) * 1990-04-26 1995-08-24 Procter & Gamble Company, The Chelator compositions comprising oxime compounds
KR950000032A (ko) * 1993-06-09 1995-01-03 류경열 맛참기름 제조방법

Also Published As

Publication number Publication date
WO1996040042A3 (en) 1997-02-06
AU6164196A (en) 1996-12-30
EP0843548A4 (en) 1998-10-28
MX9709431A (es) 1998-10-31
JPH11507359A (ja) 1999-06-29
BR9608721A (pt) 1999-10-13
EP0843548A2 (en) 1998-05-27
WO1996040042A2 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
Ebelt et al. Influence of melatonin on free radical‐induced changes in rat pancreatic beta‐cells in vitro
EP0831777B1 (en) Dinucleotides useful for the treatment of lung disease
US5683675A (en) Method of treating retained pulmonary secretions
JP3361523B2 (ja) 免疫系の調節
CA2386990C (en) Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
JP3350061B2 (ja) エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物
CZ9902257A3 (cs) Intranasální farmaceutické prostředky pro léčení sexuálních poruch
EP3592430B1 (en) Antimicrobial compounds, compositions, and uses thereof
US3809714A (en) Novel ester of ((methylamino)methyl) benzyl alcohol
Al-Ghananeem et al. Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugs
NZ335540A (en) Method of treating bronchitis with uridine triphosphates and other purinergic receptor agonists
US20070243262A1 (en) Stable S-nitrosothiol formulations
WO1992011016A1 (en) Pharmaceutical composition containing uridine 5'-triphosphate for the treatment of cystic fibrosis
WO1999039716A1 (fr) Substances preventives et medicaments destines aux maladies neurodegeneratives
CA2223385A1 (en) Stabilized steroid compositions
Antonini et al. Deaza analogues of adenosine as inhibitors of blood platelet aggregation
IL148241A (en) Composition for inhalation containing delta-9-tetrahydrocannabinol
EP1137398B1 (en) Pharmaceutical preparation for inhalation of an opioid
GB2162745A (en) Nasal compositions
EP3369816B1 (en) Composition stably containing single-stranded nucleic acid molecule that suppresses expression of tgf-beta1 gene
US20220016078A1 (en) Methods Of Treating Kidney Stones
KR20030096456A (ko) 항산화제인 알킬아릴 폴리에테르 알콜 중합체
WO2019236521A1 (en) Methods and formulations for intranasal administration
MXPA97009431A (en) Steroid compositions stabilized and use of mis
WO1994006425A1 (en) OXIDIZATION METABOLITES OF 5α-23-METHYL-4-AZA-21-NOR-CHOL-1-ENE-3,20-DIONE

Legal Events

Date Code Title Description
FZDE Dead